Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease
- PMID: 9675319
- DOI: 10.1016/s0006-8993(98)00514-9
Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease
Abstract
The precursor of non-amyloid beta protein component of Alzheimer's disease amyloid (NACP/alpha-synuclein) is aggregated and fibrillated under certain conditions, i.e., increasing time lag, high temperature and low pH. These in vitro aggregates form Thioflavine-S-positive filamentous structures, reminiscent of amyloid-like fibrils. Since some Lewy bodies in Parkinson's disease display Thioflavine-S reactivity, our results may suggest that amyloidogenic properties of NACP/alpha-synuclein may play a crucial role in pathogenesis of disorders with Lewy bodies such as Parkinson's disease.
Copyright 1998 Elsevier Science B.V. All rights reserved.
Similar articles
-
Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.Neuroreport. 1999 Mar 17;10(4):717-21. doi: 10.1097/00001756-199903170-00011. Neuroreport. 1999. PMID: 10208537
-
Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.Lab Invest. 1998 Sep;78(9):1169-77. Lab Invest. 1998. PMID: 9759660
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.Biochim Biophys Acta. 2000 Jul 26;1502(1):95-109. doi: 10.1016/s0925-4439(00)00036-3. Biochim Biophys Acta. 2000. PMID: 10899435 Review.
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
Cited by
-
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.Brain. 2016 Dec;139(Pt 12):3217-3236. doi: 10.1093/brain/aww238. Epub 2016 Sep 27. Brain. 2016. PMID: 27679481 Free PMC article.
-
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy.Elife. 2019 Dec 9;8:e48907. doi: 10.7554/eLife.48907. Elife. 2019. PMID: 31815671 Free PMC article.
-
Drug targets from genetics: α-synuclein.CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):712-23. doi: 10.2174/187152711797247867. CNS Neurol Disord Drug Targets. 2011. PMID: 21838671 Free PMC article. Review.
-
Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.Neurosci Lett. 2008 Apr 11;435(1):24-9. doi: 10.1016/j.neulet.2008.02.014. Epub 2008 Feb 12. Neurosci Lett. 2008. PMID: 18314273 Free PMC article.
-
Neuropathological alterations in Alzheimer disease.Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189. doi: 10.1101/cshperspect.a006189. Cold Spring Harb Perspect Med. 2011. PMID: 22229116 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources